Stock Earnings

Question 1

What are Xenon Pharmaceuticals Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Xenon Pharmaceuticals Inc has a total asset of $798, Net loss of $-234

Question 2

What are the key financial ratios for XENE?

Accepted Answer

Xenon Pharmaceuticals Inc's Current ratio is 18.55, has a Net margin is 0, sales per share of $0.

Question 3

How is Xenon Pharmaceuticals Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Xenon Pharmaceuticals Inc data is not available.

Question 4

Is Xenon Pharmaceuticals Inc profitable?

Accepted Answer

no, according to the latest financial statements, Xenon Pharmaceuticals Inc has a net loss of $-234

Question 5

Does Xenon Pharmaceuticals Inc have any liabilities?

Accepted Answer

yes, Xenon Pharmaceuticals Inc has liability of 43

Question 6

How many outstanding shares for Xenon Pharmaceuticals Inc?

Accepted Answer

Xenon Pharmaceuticals Inc has a total outstanding shares of 76.41

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	7	0	0	9	18	32
Revenue Growth (YoY)	--	--	-100%	-50%	-44%	433%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	75	68	46	32	21	12
Research & Development	272	210	167	105	75	50
Operating Expenses	348	279	214	138	97	63
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-309	-238	-182	-125	-78	-29
Income Tax Expense	-3	-4	0	0	0	0
Net Income	-306	-234	-182	-124	-77	-28
Net Income Growth	44%	28.99%	47%	61%	175%	-30%
Shares Outstanding (Diluted)	79.24	77.89	66.88	60.54	43.63	34.54
Shares Change (YoY)	2%	16%	10%	39%	26%	33%
EPS (Diluted)	-3.88	-3	-2.72	-2.06	-1.77	-0.81
EPS Growth	42%	10%	32%	16%	119%	-47%
Free Cash Flow	-253	-184	-156	-101	-71	-50
Free Cash Flow Per Share	-3.19	-2.36	-2.33	-1.66	-1.62	-1.44
Gross Margin	--	--	--	--	--	--
Operating Margin	-4,857.14%	0%	0%	-1,433.33%	-433.33%	-96.87%
Profit Margin	-4,371.42%	0%	0%	-1,377.77%	-427.77%	-87.5%
Free Cash Flow Margin	-3,614.28%	0%	0%	-1,122.22%	-394.44%	-156.25%
EBITDA	-338	-277	-212	-128	-78	-31
EBITDA Margin	-4,828.57%	0%	0%	-1,422.22%	-433.33%	-96.87%
D&A For EBITDA	2	2	2	1	0	0
EBIT	-340	-279	-214	-129	-78	-31
EBIT Margin	-4,857.14%	0%	0%	-1,433.33%	-433.33%	-96.87%
Effective Tax Rate	0.97%	1.68%	0%	0%	0%	0%

Xenon Pharmaceuticals Inc (XENE) Price